Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
XERS · against 430 other Healthcare companies of similar size
Ranked #414 of 431 · scores higher than 4% of peers · safety percentile 6
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)38 peers with a safety percentile of 0–9, including XERS · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | XERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 408 reported | Not reported | 0.23× | — | — | 33% |
| BetaLower is better · 406 reported | 0.85 | 0.53 | 32% | 33% | |
| Current ratioHigher is better · 416 reported | 1.45× | 2.80× | 22% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 3.6B USD | 99 | ||
| 410 | 1.9B EUR (≈$2.1B) | 6 | 52 | |
| 411 | 13.9B SEK (≈$1.4B) | 6 | 48 | |
| 412 | 14.2B CNY (≈$2.0B) | 6 | 10 | |
| 413 | 18.7B CNY (≈$2.6B) | 6 | 51 | |
| 414 | 1.9B USD | 6 | 47 | |
| 415 | 1.5B AUD (≈$982M) | 5 | 54 | |
| 416 | 1.7B USD | 5 | 31 | |
| 417 | 1.2B USD | 5 | 39 | |
| 418 | 1.4B USD | 4 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score